{"schema_version":"secwatch.filing_event.v1","accession":"0000950159-24-000103","form_type":"8-K","ticker":"CI","cik":"0001739940","company_name":"Cigna Group","filed_at":"2024-03-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.360246+00:00","generated_at":"2026-06-05T01:41:57.775872+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Cigna raises long-term adjusted EPS growth target to 10%-14%; reaffirms FY2024 guidance of at least $28.25","bullets":["Long-term average annual adjusted EPS growth target raised to 10%-14% from prior target.","2024 adjusted EPS guidance reaffirmed at least $28.25 per share.","Launches EncircleRx: industry-first financial guarantee for GLP-1s to help cap employer costs.","Evernorth Behavioral Care Group launched; guarantees appointment within 72 hours, scales by 2025.","Evernorth plans Humira biosimilar at $0 out-of-pocket for eligible Accredo patients by end of 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950159-24-000103","json":"https://secwatch.observer/filing/0000950159-24-000103.json","markdown":"https://secwatch.observer/filing/0000950159-24-000103.md","text":"https://secwatch.observer/filing/0000950159-24-000103.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1739940/000095015924000103/0000950159-24-000103-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1739940/000095015924000103/cigna8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T01:41:57.775872+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}